KIM FOREST (6645) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 金萬林-創

KIM FOREST (6645) reported revenue of NT$83.2 million for Oct 2026, +40.3% year on year and -0.5% from the previous month. Revenue for Jan–Oct 2026 was NT$578 million (+33.9% year on year).

Year-on-year revenue growth: 6 months in a row. →

In Oct 2026, it ranked No. 84 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$47.5 million24/10Nov 2024 NT$51.1 millionDec 2024 NT$60.7 millionJan 2025 NT$33.2 millionFeb 2025 NT$32 million25/02Mar 2025 NT$37.1 millionApr 2025 NT$41.1 millionMay 2025 NT$38.5 millionJun 2025 NT$45.9 million25/06Jul 2025 NT$48.4 millionAug 2025 NT$54.8 millionSep 2025 NT$41.1 millionOct 2025 NT$59.3 million25/10Nov 2025 NT$56 millionDec 2025 NT$61.6 millionJan 2026 NT$45.1 millionFeb 2026 NT$35.9 million26/02Mar 2026 NT$42.6 millionApr 2026 NT$34.8 millionMay 2026 NT$54 millionJun 2026 NT$66.1 million26/06Jul 2026 NT$63.1 millionAug 2026 NT$69.6 millionSep 2026 NT$83.6 millionOct 2026 NT$83.2 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$83.2 million+40.3%-0.5%
Sep 2026NT$83.6 million+103.5%+20.1%
Aug 2026NT$69.6 million+27.0%+10.3%
Jul 2026NT$63.1 million+30.4%-4.4%
Jun 2026NT$66.1 million+43.9%+22.4%
May 2026NT$54 million+40.1%+55.3%
Apr 2026NT$34.8 million-15.5%-18.4%
Mar 2026NT$42.6 million+14.9%+18.8%
Feb 2026NT$35.9 million+12.0%-20.5%
Jan 2026NT$45.1 million+35.8%-26.7%
Dec 2025NT$61.6 million+1.5%+10.0%
Nov 2025NT$56 million+9.5%-5.6%
Oct 2025NT$59.3 million+24.8%+44.3%
Sep 2025NT$41.1 million-11.5%-25.0%
Aug 2025NT$54.8 million+30.6%+13.3%
Jul 2025NT$48.4 million+34.1%+5.5%
Jun 2025NT$45.9 million-7.2%+19.2%
May 2025NT$38.5 million-4.0%-6.4%
Apr 2025NT$41.1 million+29.9%+10.9%
Mar 2025NT$37.1 million+2.0%+15.8%
Feb 2025NT$32 million+6.1%-3.7%
Jan 2025NT$33.2 million+11.2%-45.2%
Dec 2024NT$60.7 million+17.2%+18.6%
Nov 2024NT$51.1 million+3.2%+7.6%
Oct 2024NT$47.5 million+94.6%+2.3%

Jan–Oct 2026 cumulative: NT$578 million (+33.9% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: KIM FOREST vs PEC / KIM FOREST vs Lotus Pharm / KIM FOREST vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16